Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03826472 · ClinicalTrials.gov registry record · Phase 2
Almond Butter and Fasting Glucose
A Phase 2 study of Type2 Diabetes, sponsored by Penn State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03826472 is a Phase 2 study of Type2 Diabetes that has completed, run by Penn State University. The registered enrollment target is 10 participants, below the 47,822-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03826472, a Phase 2 study of Type2 Diabetes, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
A two-period randomized crossover study will be conducted to determine the effect of almond butter as an evening snack on fasting blood glucose in adults with type 2 diabetes, not taking insulin.
Conditions Studied
Interventions
- OTHER Almond Butter
Study Locations (1)
Pennsylvania
- Penn State - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-03-08 |
| Est. Completion | 2020-03-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03826472
The ClinicalTrials.gov registry entry for NCT03826472 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47,822-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Almond Butter is the first listed.
NCT03826472 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03826472 about?
NCT03826472 is a clinical study titled "Almond Butter and Fasting Glucose". A two-period randomized crossover study will be conducted to determine the effect of almond butter as an evening snack on fasting blood glucose in adults with type 2 diabetes, not taking insulin.
What is the current status of trial NCT03826472?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2019-03-08. Estimated completion is 2020-03-01.
What conditions does trial NCT03826472 study?
This clinical trial studies the following conditions: Type2 Diabetes.
What interventions are being tested in trial NCT03826472?
The interventions under investigation include: Almond Butter (OTHER).
Who is sponsoring clinical trial NCT03826472?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03826472 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol
COMPLETED · Phase 2
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan
RECRUITING · Early Phase 1
-
A Causative Role for Amylin in Diabetic Peripheral Neuropathy
RECRUITING
-
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
RECRUITING
-
Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.